CSIMarket
 


Abbott Laboratories  (ABT)
Other Ticker:  
 
 

ABT's Operating Income Growth by Quarter and Year

Abbott Laboratories's Operating Income results by quarter and year




ABT Operating Income (in millions $) FY 2021 FY 2020 FY 2019 FY 2018
IV Quarter December - 2,432.00 1,389.00 1,165.00
III Quarter September - 1,495.00 1,198.00 995.00
II Quarter June - 672.00 1,206.00 882.00
I Quarter March 2,109.00 758.00 739.00 608.00
FY   2,109.00 5,357.00 4,532.00 3,650.00



ABT Operating Income first quarter 2021 Y/Y Growth Comment
Abbott Laboratories achieved in the first quarter, above Company average Operating Income surge of 178.23% year on year, to $ 2,109.00 millions.

Looking into first quarter results within Major Pharmaceutical Preparations industry 5 other companies have achieved higher Operating Income growth. While Abbott Laboratories' s Operating Income doubling of 178.23% ranks overall at the positon no. 306 in the first quarter.

Explain Operating Income growth


ABT Operating Income ( Y/Y Growth %) 2021
2020 2019 2018
IV Quarter December - 75.09 % 19.23 % 68.6 %
III Quarter September - 24.79 % 20.4 % 22.84 %
II Quarter June - -44.28 % 36.73 % 106.56 %
I Quarter March 178.23 % 2.57 % 21.55 % -
FY   - 18.2 % 24.16 % 111.47 %

Financial Statements
Abbott Laboratories's first quarter 2021 Operating Income $ 2,109.00 millions ABT's Income Statement
Abbott Laboratories's first quarter 2020 Operating Income $ 758.00 millions Quarterly ABT's Income Statement
New: More ABT's historic Operating Income Growth >>


ABT Operating Income (Quarter on Quarter Growth %)

2021
2020 2019 2018
IV Quarter December - 62.68 % 15.94 % 17.09 %
III Quarter September - 122.47 % -0.66 % 12.81 %
II Quarter June - -11.35 % 63.19 % 45.07 %
I Quarter March -13.28 % -45.43 % -36.57 % -12.01 %
FY (Year on Year)   - 18.2 % 24.16 % 111.47 %




Operating Income first quarter 2021 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #6
Healthcare Sector #19
Overall #306

Operating Income Y/Y Growth Statistics
High Average Low
64.74 % 1.12 % -54.93 %
(Dec. 31. 2007)   (Sep. 30, 2015)
Operating Income first quarter 2021 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #6
Healthcare Sector #19
Overall #306
Operating Income Y/Y Growth Statistics
High Average Low
64.74 % 1.12 % -54.93 %
(Dec. 31. 2007)   (Sep. 30, 2015)

Operating Income by Quarter for the Fiscal Years 2018, 2019, 2020, 2021

Abbott Laboratories's Q/Q Operating Income Growth


Operating Income Q/Q Growth Statistics
High Average Low
313.29 % 14 % -75.54 %
(June 30. 2012)  


ABT's I. Quarter Q/Q Operating Income Comment
In the I. Quarter 2021 Abbott Laboratories disclosed drop in Operating Income sequentially by -13.28% to $ 2,109.00 millions, from $ 2,432.00 millions declared in the previous reporting period.

It's not important concern, as Operating Income always tend to plunge in this quarter Isaac  Thompson, an industry consultant told.

Within Major Pharmaceutical Preparations industry 14 other companies have achieved higher Operating Income quarter on quarter growth. While Abbott Laboratories's Operating Income growth quarter on quarter, overall rank is 829.


Operating Income Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #15
Healthcare Sector #53
Overall #829
Operating Income Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #15
Healthcare Sector #53
Overall #829
Operating Income Q/Q Growth Statistics
High Average Low
313.29 % 14 % -75.54 %
(June 30. 2012)  


ABT's I. Quarter Q/Q Operating Income Comment
In the I. Quarter 2021 Abbott Laboratories realized drop in Operating Income from the previous quarter by -13.28% to $ 2,109.00 millions, from $ 2,432.00 millions released in the previous quarter.

This is not big issue, as I. Quarter Operating Income generally seem to dip in this quarter Isaac  Thompson, an industry consultant noted.

Within Major Pharmaceutical Preparations industry 14 other companies have achieved higher Operating Income quarter on quarter growth. While Abbott Laboratories's Operating Income growth quarter on quarter, overall rank is 829.


Abbott Laboratories's 12 Months Operating Income Growth Year on Year


Operating Income TTM Growth

12 Months Ending
(Mar 31 2021)
12 Months Ending
(Dec 31 2020)
12 Months Ending
(Sep 30 2020)
12 Months Ending
(Jun 30 2020)
12 Months Ending
(Mar 31 2020)
Cumulative Operating Income 12 Months Ending $ 6,708.00 $ 5,357.00 $ 4,314.00 $ 4,017.00 $ 4,551.00
Y / Y Operating Income Growth (TTM) 47.4 % 18.2 % 0.14 % -2.14 % 20.36 %
Year on Year Operating Income Growth Overall Ranking # 225 # 223 # 714 # 918 # 534
Seqeuential Operating Income Change (TTM) 25.22 % 24.18 % 7.39 % -11.73 % 0.42 %
Seq. Operating Income Growth (TTM) Overall Ranking # 306 # 483 # 802 # 1492 # 179




Cumulative Operating Income growth Comment
Abbott Laboratories saw improvement in Operating Income growth trend, posting cumulative 12 months Operating Income growth of 47.4% year on year, to $ 6,708 millions if the fiscal year would have ended in Mar 31 2021.
Abbott Laboratories's trailing twelve months Operating Income growth was higher than company's average 9.94% and higher than 18.2% growth in Dec 31 2020.
But from twelve months ended Dec 31 2020 rise was slower at 25.22 % from $5357 millions reported in twelve months ending a quarter Dec 31 2020.
Yet it was evidence of strength, as the typical Q/Q TTM Operating Income advancement lays at 1.12%.
The momentum was much higher from the previous reporting period exhibited at 25.22 % increase from $5357 millions in twelve months ending a quarter before.

Within the Healthcare sector 22 other companies have achieved higher trailing twelve month Operating Income growth. While Operating Income growth total ranking has deteriorated compare to previous quarter from 223 to 225.

Operating Income TTM Q/Q Growth Statistics
High Average Low
64.74 %
1.12 %
-54.93 %
 

Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 6
Healthcare Sector # 23
Overall # 225

Operating Income TTM Y/Y Growth Statistics
High Average Low
157.45 %
9.94 %
-65.4 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry # 6
Sector # 19
S&P 500 # 306
Cumulative Operating Income growth Comment
Abbott Laboratories saw improvement in Operating Income growth trend, posting cumulative 12 months Operating Income growth of 47.4% year on year, to $ 6,708 millions if the fiscal year would have ended in Mar 31 2021.
Abbott Laboratories's trailing twelve months Operating Income growth was higher than company's average 9.94% and higher than 18.2% growth in Dec 31 2020.
But from twelve months ended Dec 31 2020 rise was beneth at 25.22 % from $5357 millions achieved in twelve months ending a quarter Dec 31 2020 Isaac  Thompson continued.
In spite of, it was validation of convincing trend, while the average sequential growth is at 1.12%.
The progress was much higher from twelve months ended Dec 31 2020 exhibited at 25.22 % rise from $5357 millions in the period from Dec 31 2020 to Mar 31 2020.

Within the Healthcare sector 22 other companies have achieved higher trailing twelve month Operating Income growth. While Operating Income growth total ranking has deteriorated compare to previous quarter from 223 to 225.

Operating Income TTM Q/Q Growth Statistics
High Average Low
64.74 %
1.12 %
-54.93 %
 


Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 6
Healthcare Sector # 23
Overall # 225

Operating Income TTM Y/Y Growth Statistics
High Average Low
157.45 %
9.94 %
-65.4 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry # 6
Sector # 19
S&P 500 # 306




Other Operating Income Growth
Major Pharmaceutical Preparations Industry Operating Income Growth Trends and Statistics
Healthcare Sector Operating Income Growth Statistics
Operating Income Growth Trends for overall market
ABT's Operating Income Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Operating Income Growth
Lowest Ranking Operating Income Growth
Operating Income Growth for ABT's Competitors
Operating Income Growth for Abbott Laboratories's Suppliers
Operating Income Growth for ABT's Customers

You may also want to know
ABT's Annual Growth Rates ABT's Profitability Ratios ABT's Asset Turnover Ratio ABT's Dividend Growth
ABT's Roe ABT's Valuation Ratios ABT's Financial Strength Ratios ABT's Dividend Payout Ratio
ABT's Roa ABT's Inventory Turnover Ratio ABT's Growth Rates ABT's Dividend Comparisons



Companies with similar Operating Income drop for the quarter ending Mar 31 2021 within Healthcare SectorY/Y Change %Operating Income for the quarter ending Mar 31 2021
Quest Diagnostics Inc277.14%$ 277.143 millions
U S Physical Therapy Inc274.24%$ 274.240 millions
Catalent Inc 265.67%$ 265.675 millions
Ironwood Pharmaceuticals inc 243.22%$ 243.222 millions
Option Care Health Inc 236.42%$ 236.425 millions
Align Technology inc 222.44%$ 222.443 millions
Progyny Inc 205.96%$ 205.960 millions
Repligen Corp205.59%$ 205.585 millions
Community Health Systems Inc 196.36%$ 196.364 millions
Meridian Bioscience Inc 190.06%$ 190.060 millions
Abbott Laboratories178.23%$ 178.232 millions
Surgery Partners Inc 173.62%$ 173.617 millions
Boston Scientific Corporation153.42%$ 153.425 millions
Iradimed Corp141.04%$ 141.037 millions
Teva Pharmaceutical Industries Ltd127.23%$ 127.225 millions
Insulet Corporation117.33%$ 117.333 millions
Bristol Myers Squibb Co112.81%$ 112.806 millions
Alr Technologies Inc 110.35%$ 110.345 millions
West Pharmaceutical Services Inc 99.55%$ 99.545 millions
Mednax Inc 98.99%$ 98.994 millions
Rigel Pharmaceuticals Inc98.58%$ 98.578 millions


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

BOOT's Profile

Stock Price

BOOT's Financials

Business Description

Fundamentals

Charts & Quotes

BOOT's News

Suppliers

BOOT's Competitors

Customers & Markets

Economic Indicators

BOOT's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071